Ocuphire Pharma Results
Global Prevalence of Diabetes-Associated Retinal Disease
DR Affects 1 in 3 People with Diabetes; DME Affects 1 in 13 People with Diabetes 1
Ocuphire
PHARMA
North America
& Caribbean
DR: 16M*
DME: 6M*
USA
DR: 8M²
DME: 0.75M²
DR: 4M*
DME: 4M*
DR: 18M*
DME: 8M*
DR: 7M*
DME: 4M*
DR: 15M*
DME: 5M*
*Global estimates are provided by the National Eye Institute, FactSheet, Global Data, Research and Markets, American Academy of Ophthalmology, and PLOS One
1. Holekamp N. M. (2016). Overview of diabetic macular edema. The American journal of managed care, 22(10 Suppl), s284-s291.
2. American Diabetes Association; American Journal of Managed Care, International Diabetes Federation; Healthline; Ocuphire internal analysis and assumptions
DR: 11M*
DME: 7M*
DR: 32M*
DME: 14M*
13View entire presentation